Cardiac autonomic neuropathy: role of metabolic therapy
- Authors: Kotova O.V1, Akarachkova E.S1
-
Affiliations:
- I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 18, No 4 (2016)
- Pages: 28-30
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/94435
- ID: 94435
Cite item
Full Text
Abstract
Neuropathy is one of the most common complications of diabetes mellitus (DM) and affects about 60% of patients. Patients with type 2 DM can have this complication after several years of poor glycemic control, and sometimes these patients already have neuropathy at the time of DM diagnosis. Diabetic autonomic neuropathy (DAN) is a type of diabetic peripheral neuropathy. Whereas, cardiac autonomic neuropathy (CAN) is a type of diabetic autonomic neuropathy and the most commonly form of DAN. It is now known that 50% of patients with DM suffering from diabetic neuropathy have asymptomatic CAN (form of diabetic autonomic neuropathy - DAN), while 100% of patients with symptoms of CAN have classic diabetic neuropathy. Orthostatic hypotension (OH) is a common manifestation of CAN. In general, the prevalence of OH among elderly patients is 54-68% and 6% in the general population. OH is a serious problem primarily because of the impact on the course of chronic somatic diseases. The existence of OH is an independent risk factor for incidence of myocardial infarction (and for mortality as well), stroke, heart failure and arrhythmias. This article deals with Ewing’s five standard tests for diagnosing cardiovascular pathology. This article discusses the possibility of prescribing preparations of a-lipoic acid, vitamin B preparations, preparations containing vitamin B-complex and biologically active substances in the capacity of possible pathogenetic DAN therapy. Cocarnit is a complex preparation, containing vitamins B and metabolically active compounds, which can improve total somatical state of patients with DAN.
Full Text
##article.viewOnOriginalSite##About the authors
O. V Kotova
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: ol_kotova@mail.ru
канд. мед. наук, ст. науч. сотр., врач-невролог НИО неврологии НИЦ ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
E. S Akarachkova
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federationд-р мед. наук, вед. науч. сотр., врач-невролог ГБОУ ВПО Первый МГМУ им. И.М. Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
References
- Dyck P.J, Kratz K.M, Karnes J.L et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population - based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43 (4): 817-24; PMID: 8469345 doi: 10.1212/wnl.43.4.817
- Timar B, Timar R, Gaiă L . The Impact of Diabetic Neuropathy on Balance and on the Risk of Falls in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. PLoS One 2016; 11 (4): e0154654; doi: 10.1371/journal.pone.0154654. eCollection 2016
- Vinik A.I, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 2001; 68: 928-30.
- Vinik A.I, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 387-97.
- Low P.A, Vernino S, Suarez G. Autonomic dysfunction in peripheral nerve disease. Muscle Nerve 2003; 27: 646-61.
- Dyck P.J.B, Norell J.E, Dyck P.J. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999; 53: 2113-21.
- Vinik A.I, Casellini C, Névoret M.L. Alternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy. Rev Neurobiol 2016; 127: 235-85; doi: 10.1016/bs.irn.2016.03.010
- Tahrani A.A, Dubb K, Raymond N.T et al. Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study. Diabetologia 2014; 57 (6): 1249-56; doi: 10.1007/s00125-014-3211-2. PMID: 24623102
- Dimitropoulos G, Tahrani A.A, Stevens M.J. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes 2014; 5 (1): 17-39; doi: 10.4239/wjd.v5.i1.17. PMID: 24567799
- Shibao C, Grijalva C.G, Raj S.R et al. Orthostatic hypotension - related hospitalizations in the United Sates. Am J Med 2007; 120 (11): 975-80.
- Ricci F, De Caterina R, Fedorowski A. Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment. J Am Coll Cardiol 2015; 66 (7): 848-60.
- Veronese N, De Rui M, Bolzetta F et al. Orthostatic changes in blood pressure and mortality in the elderly: the Pro.V.A Study. Am J Hypertens 2015.
- Lacigova S, Brozova J, Cechurova D et al. The influence of cardiovascular autonomic neuropathy on mortality in type 1 diabetic patients; 10-year follow - up. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016; 160 (1): 111-7; doi: 10.5507/bp.2015.063
- Ewing D.J, Martyn C.N, Young R.J, Clarke B.F. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-8.
- Котова О.В. Диабетическая автономная полиневропатия. Фарматека. 2012; 6: 40-4.
- Котова О.В. Диабетическая нейропатия. Применение нейротропных витаминов. Поликлиника. 2015; 1 (2): 36-9.
- Popov S.V, Melekhovets' O.K, Demikhova N.V, Vynnychenko L.B. Drug with a high metabolic activity, cocarnit, in the treatment of diabetic cardiac autonomic neuropathy. Lik Sprava 2012; 3-4: 75-81.
Supplementary files
